Julia Lainster

Julia Lainster

HealthTech Solutions Expert
Julia Lainster is an expert in Healthtech with a focus on electronic health records, interoperability standards, and cybersecurity. Her content is geared toward industry leaders and organizations seeking to leverage technology to improve efficiency, accuracy, and security in healthcare delivery. Julia aims to drive digital transformation and innovation in Healthtech.
Is Luvelta the Next Breakthrough Drug for Treating NSCLC?
Research & Development Is Luvelta the Next Breakthrough Drug for Treating NSCLC?

Sutro Biopharma has announced a significant step forward in the fight against lung cancer by initiating a global Phase 2 clinical trial, aptly named REFRαME-L1, for their innovative drug luveltamab tazevibulin (luvelta). This trial aims to evaluate the safety and efficacy of luvelta in adults with

Lilly's Tirzepatide Shows 94% Reduction in Diabetes Risk and Weight Loss
Research & Development Lilly's Tirzepatide Shows 94% Reduction in Diabetes Risk and Weight Loss

Eli Lilly's groundbreaking medication, tirzepatide, also known as Mounjaro and Zepbound, has demonstrated remarkable success in reducing the risk of Type 2 diabetes and promoting weight loss. The results from the extensive Phase 3 trial, named SURMOUNT-1, have sparked significant interest and

FDA Lifts Hold on BioNTech and MediLink’s Cancer Drug Trial
Research & Development FDA Lifts Hold on BioNTech and MediLink’s Cancer Drug Trial

In an impressive turn of events, the U.S. Food and Drug Administration (FDA) has lifted the partial hold on BioNTech and MediLink Therapeutics' clinical trial for their groundbreaking Antibody-Drug Conjugate (ADC) candidate BNT326/YL202. Originally put on hold due to serious safety concerns, the

How Is VGXI Shaping the Future of Biopharmaceutical Manufacturing?
Management & Regulatory How Is VGXI Shaping the Future of Biopharmaceutical Manufacturing?

VGXI Inc., a prominent Contract Development and Manufacturing Organization (CDMO) specializing in nucleic acid biopharmaceuticals, is making significant strides in the biopharmaceutical industry. Their recent inclusion in the Biopharmaceutical Manufacturing Preparedness (BioMAP) Consortium

How is Biopharma Revolutionizing Patient Care and Medical Treatments?
Tech & Innovation How is Biopharma Revolutionizing Patient Care and Medical Treatments?

The biopharmaceutical industry, or biopharma, stands at the forefront of medicine and biotechnology, bringing revolutionary advancements to patient care and medical treatments. Biopharma focuses on developing drugs from biological sources, offering a wide range of therapies that are changing lives.

How Is Maccabi Health Services Bolstering Cybersecurity with Cynerio?
Tech & Innovation How Is Maccabi Health Services Bolstering Cybersecurity with Cynerio?

Maccabi Health Services has taken a significant step toward safeguarding its medical and Internet of Things (IoT) devices from ransomware attacks by partnering with Cynerio, a startup specializing in healthcare cybersecurity. Being the second-largest health maintenance organization in Israel, which

Can a Dissolvable Microneedle Patch Revolutionize Periodontitis Treatment?
Biotech & Bioprocessing Can a Dissolvable Microneedle Patch Revolutionize Periodontitis Treatment?

Periodontitis remains one of the most common chronic inflammatory diseases affecting millions globally, characterized by an imbalance in the oral microbiome and prompted by pathogenic bacteria. Due to this imbalance, the body's immune response becomes inefficient, resulting in harm to surrounding

Can Prelaminated Flaps Revolutionize Human Lip Reconstruction?
Biotech & Bioprocessing Can Prelaminated Flaps Revolutionize Human Lip Reconstruction?

Human lips, being complex structures formed of mucosa, skin, and innervated skeletal muscles, are essential for various daily activities such as eating, drinking, talking, and social interactions. This makes their reconstruction, especially after traumatic injuries or cancer surgeries, a

How Will Jim Wilson’s Exit from UPenn Impact Gene Therapy?
Research & Development How Will Jim Wilson’s Exit from UPenn Impact Gene Therapy?

Jim Wilson, a seminal figure in the field of gene therapy, is departing the University of Pennsylvania (UPenn) after an illustrious career spanning decades. His decision to step down marks a significant juncture for both the institution and the broader gene therapy landscape. Over the years, Wilson

US Lawmakers Intensify Scrutiny on Chinese Firms in Biotech Sector
Tech & Innovation US Lawmakers Intensify Scrutiny on Chinese Firms in Biotech Sector

The article delves into the escalating scrutiny by US lawmakers on Chinese biotech and medtech companies, which they allege pose significant national security risks. These legislative actions are part of a broader strategy to curb Chinese influence and secure US technology and intellectual

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later